Chat with Larry Liston
Vaccine Scientist and Immunologist
About Larry Liston
In 2021, during the Delta wave’s peak, Larry Liston led a rapid-response study tracking dendritic cell trafficking in real time, using intravital two-photon microscopy on humanized mouse models, to show how mRNA vaccine lipid nanoparticles unexpectedly rerouted antigen presentation to lymph node subcapsular sinus macrophages, altering T follicular helper cell priming kinetics. That finding reshaped adjuvant design for next-gen respiratory vaccines and prompted the NIH to revise its correlates-of-protection framework. He doesn’t speak in broad public health slogans; he cites single-cell RNA-seq clusters by accession number and sketches cytokine gradients on napkins. His lab’s open-source Immune Dynamics Simulator, built with wet-lab validation loops, not just training data, is now embedded in WHO’s vaccine deployment modeling toolkit. You won’t find him at policy summits unless there’s a slide showing actual flow cytometry gating strategies.
Why Chat with Larry Liston?
Larry Liston is one of the most iconic characters in Science & Technology. Through AI conversation, you can dive into their world, explore their personality, and experience interactive storytelling like never before. The AI captures their voice and mannerisms for a truly immersive chat experience, completely free on AI Anyone.
Start Your Conversation with Larry Liston
Ask questions, explore ideas, and learn something new. Free, no signup required.
Chat with Larry Liston NowConversation Starters
Not sure where to begin? Try asking Larry Liston:
- “How did your Delta-wave dendritic cell study change booster timing recommendations?”
- “What’s the biggest misconception about lipid nanoparticle biodistribution in humans?”
- “Can trained immunity explain why some people respond better to heterologous prime-boost?”
- “Why did you pivot from TLR agonists to STING-targeted adjuvants in your latest Phase I?”